News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
633,217 Results
Type
Article (31509)
Company Profile (693)
Press Release (601015)
Section
Business (196002)
Career Advice (2090)
Deals (36040)
Drug Delivery (97)
Drug Development (77214)
Employer Resources (161)
FDA (15050)
Job Trends (14539)
News (330042)
Policy (28440)
Tag
Academia (1223)
Alliances (46394)
Alzheimer's disease (1179)
Approvals (14993)
Artificial intelligence (137)
Bankruptcy (364)
Best Places to Work (10758)
Biotechnology (475)
Breast cancer (161)
Cancer (1242)
Cardiovascular disease (100)
Career advice (1722)
Cell therapy (281)
Clinical research (62241)
Collaboration (481)
Compensation (257)
COVID-19 (2128)
C-suite (119)
Data (1332)
Diabetes (159)
Diagnostics (6115)
Earnings (81134)
Employer resources (139)
Events (106575)
Executive appointments (399)
FDA (15667)
Funding (412)
Gene therapy (184)
GLP-1 (601)
Government (2776)
Healthcare (15666)
Infectious disease (2216)
Inflammatory bowel disease (110)
Interviews (420)
IPO (17009)
Job creations (4202)
Job search strategy (1432)
Layoffs (480)
Legal (7048)
Lung cancer (181)
Manufacturing (221)
Medical device (13324)
Medtech (13329)
Mergers & acquisitions (19184)
Metabolic disorders (442)
Neuroscience (1508)
NextGen Class of 2024 (5917)
Non-profit (1854)
Northern California (1687)
Obesity (255)
Opinion (226)
Patents (117)
People (55693)
Pharmaceutical (141)
Phase I (19582)
Phase II (27846)
Phase III (20593)
Pipeline (514)
Postmarket research (1895)
Preclinical (7855)
Radiopharmaceuticals (249)
Rare diseases (253)
Real estate (5660)
Regulatory (19905)
Research institute (1272)
Resumes & cover letters (330)
Southern California (1436)
Startups (3858)
United States (15128)
Vaccines (533)
Weight loss (189)
Date
Last 7 days (590)
Last 30 days (2304)
Last 365 days (35440)
2024 (35277)
2023 (40199)
2022 (50317)
2021 (53448)
2020 (50465)
2019 (41630)
2018 (31835)
2017 (32298)
2016 (30399)
2015 (35794)
2014 (28460)
2013 (23447)
2012 (25032)
2011 (25203)
2010 (23091)
Location
Africa (658)
Arizona (127)
Asia (39198)
Australia (6383)
California (3884)
Canada (1435)
China (301)
Colorado (172)
Connecticut (184)
Europe (85181)
Florida (493)
Georgia (132)
Illinois (324)
Indiana (232)
Maryland (529)
Massachusetts (3103)
Michigan (184)
Minnesota (296)
New Jersey (1104)
New York (1066)
North Carolina (824)
Northern California (1687)
Ohio (130)
Pennsylvania (900)
South America (1047)
Southern California (1436)
Texas (555)
Utah (108)
Washington State (415)
633,217 Results for "searle a monsanto company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Bayer Rolls Out New Operating Model, Eliminates Managerial Staff
The sweeping changes are meant to “reduce hierarchies” and “accelerate decision-making” as Bayer weathers several business crises and continues to suffer from the fallout of its disastrous Monsanto acquisition.
January 18, 2024
·
2 min read
·
Tristan Manalac
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
December 5, 2024
·
1 min read
·
Angela Gabriel
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Drug Development
IDEAYA Announces Results for Darovasertib Phase 2 IST in Neoadjuvant Uveal Melanoma at ASCO and Clinical Update for Phase 2 Company-Sponsored Neoadjuvant Study
IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced updated clinical results from the ongoing investigator-sponsored Phase 2 trial of darovasertib, a first-in-class oral, small molecular inhibitor of protein kinase C, as neoadjuvant/adjuvant treatment in uveal melanoma and clinical update for Phase 2 company-sponsored neoadjuvant UM study.
June 3, 2024
·
7 min read
Press Releases
Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
December 6, 2024
·
3 min read
Job Trends
Flexing on the Competition? Smaller Companies Get Higher Marks for Flexibility
Many biopharma professionals view smaller companies as having the best flexibility and remote work options, but that doesn’t mean their larger counterparts are failing in that area. Several professionals, including Apogee Therapeutics and Insmed executives, share their insights.
November 21, 2024
·
6 min read
·
Angela Gabriel
Press Releases
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
December 19, 2024
·
1 min read
Career Advice
11 Signs of Good Company Culture
Good company culture is a crucial aspect of professional life. Look at these 11 important indications of good workplace culture before accepting a job offer or use them to evaluate your new employer.
September 19, 2024
·
4 min read
·
Editorial Staff
Press Releases
Transpire Bio Achieves Important Corporate Milestone with Completion of First Human Subject Study in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program
December 18, 2024
·
1 min read
Press Releases
Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
December 2, 2024
·
3 min read
1 of 63,322
Next